Related Experiment Video
Updated: Aug 15, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Beneficial effects of interferon-alpha in a case with Behçet's disease
Behcet's disease (BD) is a rare inflammatory disorder. This case study suggests interferon-alpha may help manage BD symptoms by acting as an immunomodulatory agent.
Area of Science:
- Immunology
- Rheumatology
- Oncology
Background:
- Behcet's disease (BD) is a chronic, multisystem inflammatory disorder characterized by recurrent oral aphthae, genital ulcers, skin lesions, and ocular inflammation.
- The patient, diagnosed with BD at age 20, experienced persistent ocular manifestations and other systemic symptoms for decades.
- A concurrent diagnosis of right renal cell carcinoma led to nephrectomy and subsequent treatment with interferon-alpha (IFN-alpha).
Observation:
- The patient presented with a complex medical history including recurrent oral aphthae, genital ulcers, folliculitis, erythema nodosum, arthritis, and epididymitis.
- Ocular manifestations of BD were active and persistent from 1990 onwards.
- Following nephrectomy for renal cell carcinoma, the patient received IFN-alpha as supplemental chemotherapy.
Findings:
- During IFN-alpha administration, no active phase of Behcet's disease was observed.
- The absence of active BD symptoms suggests a potential therapeutic effect of IFN-alpha.
Implications:
- Interferon-alpha may possess immunomodulatory properties beneficial in managing Behcet's disease.
- Further research into IFN-alpha as a treatment for BD is warranted, particularly for its role in controlling inflammatory activity.
- This case highlights the potential for repurposed therapies in managing complex, chronic inflammatory conditions like Behcet's disease.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
09:11Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
Published on: July 16, 2019
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inhibitors of Viral Protein Synthesis